|
Marjori Matzke answers a few questions about this month's
new hot paper in the field of Molecular Biology & Genetics.
From
•>>May 2006
Field:
Molecular Biology & Genetics
Article Title: RNAi-mediated pathways in the nucleus
Authors: Matzke,
MA;Birchler, JA
Journal: NAT REV GENET
Volume: 6
Issue: 1
Page: 24-35
Year: JAN 2005
* Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Pharm Zentrum, UZA2,Althanstr 14-2D-541, A-1090 Vienna, Austria.
* Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Pharm Zentrum, A-1090 Vienna, Austria.
* Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.
|
Why
do you think your paper is highly cited?
This review article—co-written with Jim Birchler of the
Department of Biological Sciences at the University of
Missouri-Columbia in Columbia, Missouri—is the first to provide
equal and comprehensive coverage to all four currently known RNAi-mediated
pathways in the nucleus.
|
“It has been amazing to find over the years that homology-dependent gene silencing is a variant of what we now call
RNAi.”
|
|
Previous reviews on similar topics concentrated on only one or
two pathways —usually on RNAi-mediated heterochromatin formation
in fission yeast. Our review covered, in addition, RNA-directed DNA
methylation in plants, meiotic silencing of unpaired DNA in Neurospora,
and RNAi-mediated DNA elimination in ciliated protozoa.
Does
it describe a new discovery or a new methodology that's useful to
others?
It was initially thought that RNAi would act exclusively in the
cytoplasm to degrade mRNA. The realization that the RNAi machinery
also has a major role in guiding epigenetic modifications in the
nucleus constituted a major advance in gene silencing research.
The use of short RNAs generated by the RNAi machinery to target
DNA and histone methylation to matching sequences in the genome
permits these modifications to be induced in a highly
sequence-specific manner. Some groups are now using
promoter-directed short RNAs as an alternative to
"classical" RNAi to elicit gene silencing for functional
genomics.
Could
you summarize the significance of your paper in layman's terms?
In all organisms, gene activity must be carefully regulated so
that each cell type expresses only a subset of genes while the rest
of the genes remain silent. How is silencing targeted to specific
genes? Whereas previous ideas and experiments focused on regulatory
proteins, our review describes recent findings demonstrating an
unanticipated role for tiny regulatory RNAs in targeting genes that
have a matching sequence for silencing.
How
did you become involved in this research, and were any problems
encountered along the way?
Our lab has a long history of gene silencing research in plants,
beginning with our work in 1989 on "homology-dependent gene
silencing," which appeared to be induced by sequence-specific
interactions between identical promoter elements.
Later, we learned that this silencing phenomenon is triggered by
double-stranded RNAs containing promoter sequences. It has been
amazing to find over the years that homology-dependent gene
silencing is a variant of what we now call RNAi.
If
applicable, what are the social or political implications of your
research?
The feasibility of using promoter-directed short RNAs to induce
transcriptional gene silencing in humans for therapeutic
applications is being analyzed by several labs around the world. For
example, it might be possible to silence the promoters of viruses
via
promoter-directed short RNAs.
Marjori Matzke
Senior Scientist
Gregor Mendel Institute of Molecular Plant Biology
Austrian Academy of Sciences
Vienna, Austria
Read
a Fast Breaking Paper comment from
August 2004
by Marjori Matzke.
|
ESI Special Topics,
May 2006
Citing URL - http://www.esi-topics.com/nhp/2006/may-06-MarjoriMatzke.html
|
|